Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26F9X40
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,279
Award facts
- Contract value 100% obligated
- $12,278.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,278.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in treating autoimmune diseases. This non-set-aside contract, which is scheduled for completion by January 15, 2026, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company competes on a full and open basis for federal contracts, as evidenced by the non-set-aside designation of this award and its broader contract portfolio. Through its DLA relationship, AmerisourceBergen supplies specialty medications, brand-name and generic drugs, vaccines, and medical devices to customers including the Defense Health Agency and U.S. Coast Guard, demonstrating its established capability to fulfill government contracts for essential pharmaceutical commodities required by military treatment facilities and federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F9X40?
SPE2DR26F9X40 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F9X40 worth?
The government has obligated $12,279 on SPE2DR26F9X40.
Is contract SPE2DR26F9X40 an order under another contract?
Yes. SPE2DR26F9X40 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9X40 competed?
The extent of competition for SPE2DR26F9X40 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award